Vedanta Biosciences Jobs

Vedanta Biosciences

Scientific Services | CAMBRIDGE, MA | 98 followers

Vedanta Biosciences Overview

WEBSITE vedantabio.com
HEADQUARTERS CAMBRIDGE, MA
SIZE 50 - 100
FOUNDED 2011
CEO DAVID STEINBERG
REVENUE <$5M
INDUSTRY Scientific Services
Related Companies
Create an Alert for Vedanta Biosciences Jobs
Create a Job Alert

Get notified when new Vedanta Biosciences jobs are posted

Email Address

Search Vedanta Biosciences Jobs

Vedanta Biosciences Jobs Near Me Remote Vedanta Biosciences Jobs Part-time Vedanta Biosciences Jobs

Browse Vedanta Biosciences Jobs ( View All Jobs )

Contract - Quality Control Specialist I at Vedanta Biosciences

Cambridge, MA | Full Time
$78k-103k (estimate)
1 Month Ago
Title:                   Contract - Quality Control Specialist I. Location:           Cambridge, MA. Reports to:        Principal Quality Control Specialist. . About Vedanta Biosciences. Vedanta Biosciences. is a late-stage biopharmaceutical company developing medicines for the treatment of gastrointestinal diseases. The company’s lead assets include potential first-in-class oral therapies, VE303, a Phase 3-ready candidate for recurrent. C. diffi...

Head of Commercial at Vedanta Biosciences

Cambridge, MA | Full Time
$235k-339k (estimate)
2 Months Ago
Title:                    Head of Commercial (Vice President – Chief). Location:            Cambridge, MA. Reports to:         Chief Executive Officer. . About Vedanta Biosciences. Vedanta Biosciences. is a late-stage biopharmaceutical company developing medicines for the treatment of gastrointestinal diseases. The company’s lead assets include potential first-in-class oral therapies, VE303, a Phase 3-ready candidate for recurrent. C. difficile. ...

Senior Systems Administrator at Vedanta Biosciences

Cambridge, MA | Full Time
$105k-130k (estimate)
3 Months Ago
Title: Senior Systems Administrator. Location: Cambridge, MA. Reports to: Head of IT Infrastructure & Operations. About Vedanta Biosciences. Vedanta Biosciences is a late-stage biopharmaceutical company developing medicines for the treatment of gastrointestinal diseases. The company's lead assets include potential first-in-class oral therapies, VE303, a Phase 3-ready candidate for recurrent C. difficile infection, and VE202, in a Phase 2 trial fo...
View All Jobs
Back